Healio

Endologix acquires PQ Bypass, developer of percutaneous femoral-popliteal bypass for PAD

Please provide your email address to receive an email when new articles are posted on . Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a ...
Healio

Aortoiliac Occlusive Disease: Open vs. Endovascular Approach

The manifestation of peripheral vascular disease in the aortoiliac segment is common, and thus its management is a frequent part of the day-to-day work for a vascular surgeon or interventionalist. The ...
Business Wire

PQ Bypass Receives FDA “Breakthrough Device Designation” for the World’s First Fully Percutaneous Femoral-Popliteal Bypass Device

MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass Inc, a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease (PAD), announced today that they received ...
BioWorld

DETOUR2 shows Endologix superficial femoral artery bypass on track

One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...
News Medical

Race and socioeconomic deprivation linked to poor outcomes after lower extremity bypass

As a result, such patients were more likely to require amputation after lower extremity bypass 30 days and up to one year after the procedure than white patients and those who were not ...